Please login to the form below

Not currently logged in
Email:
Password:

Pharnext appoints COO

Amit Kohli joins the biopharma from Eurofins

Clinical-stage biopharmaceutical group Pharnext has appointed Amit Kohli as its new chief operating officer, a role which will see him take responsibility for leading Pharnext’s corporate strategy and operations.

Before joining Pharnext, Kohli was general manager of clinical diagnostics at Eurofins based in Brussels, where he led business expansion across Europe and the Middle East.

He has also held a number of leadership roles with Sanofi in sales, marketing, finance, supply chain and manufacturing.

Daniel Cohen, co-founder and chief executive officer of Pharnext, said: “Amit is a seasoned leader with over 20 years’ experience in the healthcare industry, and we are thrilled he is joining Pharnext.”

3rd May 2018

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....